Flemming Sonne of Denmark’s public hospital medicine procurement body Amgros outlines the scope and mission of the group, how its remit has increased to include security of supply in the wake of the COVID-19 pandemic, and why international collaboration and knowledge-sharing is crucial, especially in the new era of complex and expensive cell and gene therapies.
Prior to joining Amgros, I worked in pharma for nearly 15 years. Therefore, I will never be afraid of the industry; in fact, I have a deep respect for it. A lot can be achieved via collaboration but there needs to be an awareness of the different phases in the decision-making process
